Fast Facts for Patients: Colorectal Cancer with KRAS Mutation
Colorectal cancer (CRC) is cancer that begins in the colon or rectum of the digestive system. KRAS is a protein that sends signals to cells telling them to divide. In healthy cells, KRAS can be switched on and off. In some cancer cells, gene mutations cause changes in the KRAS protein that mean it is constantly switched on, driving cells to divide. KRAS mutation status can be used to guide treatment decisions. New treatments that target a KRAS mutation have been approved for non-small cell lung cancer and are now being tested for CRC. Other treatments are also being developed.
1145524901
Fast Facts for Patients: Colorectal Cancer with KRAS Mutation
Colorectal cancer (CRC) is cancer that begins in the colon or rectum of the digestive system. KRAS is a protein that sends signals to cells telling them to divide. In healthy cells, KRAS can be switched on and off. In some cancer cells, gene mutations cause changes in the KRAS protein that mean it is constantly switched on, driving cells to divide. KRAS mutation status can be used to guide treatment decisions. New treatments that target a KRAS mutation have been approved for non-small cell lung cancer and are now being tested for CRC. Other treatments are also being developed.
0.0 In Stock
Fast Facts for Patients: Colorectal Cancer with KRAS Mutation

Fast Facts for Patients: Colorectal Cancer with KRAS Mutation

Fast Facts for Patients: Colorectal Cancer with KRAS Mutation

Fast Facts for Patients: Colorectal Cancer with KRAS Mutation

eBook

FREE

Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
WANT A NOOK?  Explore Now

Related collections and offers


Overview

Colorectal cancer (CRC) is cancer that begins in the colon or rectum of the digestive system. KRAS is a protein that sends signals to cells telling them to divide. In healthy cells, KRAS can be switched on and off. In some cancer cells, gene mutations cause changes in the KRAS protein that mean it is constantly switched on, driving cells to divide. KRAS mutation status can be used to guide treatment decisions. New treatments that target a KRAS mutation have been approved for non-small cell lung cancer and are now being tested for CRC. Other treatments are also being developed.

Product Details

ISBN-13: 9783318073492
Publisher: Karger, S. Inc.
Publication date: 03/25/2024
Sold by: Barnes & Noble
Format: eBook
Pages: 38
File size: 5 MB
From the B&N Reads Blog

Customer Reviews